Announcements Trials
Browse Landscape

Phase

Phase 2 4Phase NA 3Phase 1 2Phase EARLY_PHASE1 1

Status

Recruiting 2

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Sarcoma 2Genitourinary 1Dermatologic 1

Conditions

Carcinoma, Non-Small-Cell Lung 62Neoplasms 52Neoplasm Metastasis 49Leukemia, Myeloid, Acute 48Colorectal Neoplasms 48Breast Neoplasms 44Prostatic Neoplasms 38Multiple Myeloma 34Ovarian Neoplasms 32Recurrence 29Melanoma 28Pancreatic Neoplasms 27Lymphoma, Non-Hodgkin 26Squamous Cell Carcinoma of Head and Neck 24Precursor Cell Lymphoblastic Leukemia-Lymphoma 24Myelodysplastic Syndromes 22Endometrial Neoplasms 22Triple Negative Breast Neoplasms 21Glioblastoma 20Carcinoma, Renal Cell 20Lung Neoplasms 19Advanced Solid Tumors 19Stomach Neoplasms 18Small Cell Lung Carcinoma 18Sarcoma 18Carcinoma, Hepatocellular 17Brain Neoplasms 17Lymphoma, B-Cell 14Esophageal Neoplasms 13Advanced Solid Tumor 13

Interventions

Gemcitabine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 1 × Bone Neoplasms × 30 days × Clear all
NCT03093909 2026-05-20

Study of Aerosol Gemcitabine in Patients With Solid Tumors and Pulmonary Metastases

M.D. Anderson Cancer Center

Phase 1 Recruiting
44 enrolled
DermatologicGenitourinarySarcoma

Bone Neoplasms, Melanoma, Osteosarcoma, Urologic Neoplasms

NCT07197645 2026-05-14

SOLACE

Telix Pharmaceuticals (Innovations) Pty Limited

Phase 1 Recruiting
33 enrolled
Sarcoma

Bone Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡